Studies & Statistics
Useful Articles
Sweeping
Review Finds Naltrexone Effective
Treating Alcoholism as a Chronic Disease (PDF)
Addiction in the Healthcare Professions
Today's Nurse - September 2002
Medication and Craving (PDF)
National Institute on Alcohol Abuse and Alcoholism
Stigma of Addiction
(published at www.jointogether.org)
Why Is Recovery From Alcoholism So Difficult
A
Point of View Concerning Treatment Approaches With Narcotic Antagonists (PDF)
Man
on a mission says new drug can defeat addictions
(St. Louis Post Dispatch 8-19-03)
Active
Ingredients of Effective Treatment (PDF)
Government Research & Studies
Naltrexone
Naltrexone
And Alcoholism Treatment
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
Treatment Improvement Protocol (TIP) Series 28
Presents current knowledge about the use of naltrexone, an opioid antagonist medication first synthesized in the 1960s and subsequently developed by the National Institute on Drug Abuse (NIDA). This medicine was initially developed to treat opiate addiction.
Subsequently, research sponsored by the National Institute on Alcohol Abuse
and Alcoholism, which is still ongoing, found that naltrexone can help prevent
relapse to alcohol use disorder when combined with traditional treatment modalities.
TIP 28 is available FREE, in print by calling the National
Clearinghouse for Alcohol and Drug Information at 1-800-729-6686.
Ask for DHHS Publication No. (SMA) 98-3206.
To view online click here
Suboxone® (buphrenorphine)
Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid
Addiction
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
Treatment Improvement Protocol (TIP) 40
Provides consensus and evidence-based treatment guidance for the use of buprenorphine,
a new option for the treatment of opioid addiction. The goal of this TIP is
to provide physicians with information they can use to make practical and
informed decisions about the use of buprenorphine to treat opioid addiction.
TIP 28 is available FREE, in print, by calling the National
Clearinghouse for Alcohol and Drug Information at 1-800-729-6686.
Ask for publication order number BKD504.
To
view online click here